FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Avkare Sildenafil Tablets 100 mg Recall

Sildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pula…

AVKARE Inc. · Pulaski, TN

Risk level
Class II
Reported by FDA
Dec 23, 2020
Recall ID
D-0167-2021
Check your lot numberHow we source this data

Summary

Avkare recalled Sildenafil Tablets 100 mg starting Dec 7, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0167-2021 on Dec 23, 2020. Reason: Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility. Status: Terminated.

Why it was recalled

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

Product description

Sildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-748-01.

Lot numbers, UPCs & expiration codes

Lot: 36884 Exp. 03/2022

Where it was sold

Nationwide within the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0167-2021
Classification
Class II
Status
Terminated
Recall initiated
Dec 7, 2020
FDA report date
Dec 23, 2020
Quantity
38715 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
AVKARE Inc.

Original FDA data

Every field from FDA enforcement report D-0167-2021, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Terminated
Country
United States
Event ID
86940
Address
615 N 1st St
Code information
Lot: 36884 Exp. 03/2022
Postal code
38478-2403
Report date
Dec 23, 2020
Product type
Drugs
Recall number
D-0167-2021
Classification
Class II
Recalling firm
AVKARE Inc.
Product quantity
38715 bottles
Termination date
Oct 16, 2023
Reason for recall
Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-748-01.
Distribution pattern
Nationwide within the U.S.
Recall initiation date
Dec 7, 2020
Initial firm notification
Letter
Center classification date
Dec 16, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0167-2021, published Dec 23, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls